GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Brandolini L, Grannonico M, Bianchini G, Colanardi A, Sebastiani P, Paladini A, Piroli A, Allegretti M, Varrassi G, Di Loreto S. (2019)
The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury. Neurotox Res, 36 (1): 163-174. [PMID:30953275] |
|
2. Cristiano C, Giorgio C, Cocchiaro P, Boccella S, Cesta MC, Castelli V, Liguori FM, Cuozzo MR, Brandolini L, Russo R et al.. (2023)
Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy. Cytokine, 171: 156370. [PMID:37722320] |
|
3. D'Angelo R, Mangini M, Fonderico J, Fulle S, Mayo E, Aramini A, Mariggiò S. (2020)
Inhibition of osteoclast activity by complement regulation with DF3016A, a novel small-molecular-weight C5aR inhibitor. Biomed Pharmacother, 123: 109764. [PMID:31901551] |